Hillarp A, Holme PA, Wåland EP, Le MS, Henriksson CE, Tjønnfjord GE, Måseide RJ(2023) Report on 4 cases with decreased recovery due to neutralizing antibodies specific for PEGylated recombinant factor VIII J Thromb Haemost, 21(10), 2771-2775 DOI 10.1016/j.jtha.2023.07.019, PubMed 37543216
Ettingshausen CE, Hermans C, Holme PA, Cid AR, Khair K, Oldenburg J, Négrier C, Botha J, Lelli A, Windyga J(2023) Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study Ther Adv Hematol, 14, 20406207231184323 DOI 10.1177/20406207231184323, PubMed 37529276
Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V(2023) von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction Res Pract Thromb Haemost, 7(4), 100164 DOI 10.1016/j.rpth.2023.100164, PubMed 37255854
